The ACSR collects clinical information from each patient when available, but minimally requires gender, age, HIV status and specimen diagnosis for biospecimens to be included in the inventory. Additionally, the ACSR records other available pertinent data relevant to current HIV/AIDS research goals, such as CD4 counts and treatment. For more specific information about available data, please contact the ACSR via email at CODCC@acsr.ucsf.edu.
The ACSR database contains more than 300,000 individual biospecimens with associated clinical information Please follow the following like to see the most current summary of the types of cancers and specimens in the general collection. Investigators interested in requesting biospecimens are highly encouraged to address their inquiries directly to ACSR staff for complete and up to date information regarding biospecimen availability. For assistance, contact us.
Each ACSR Regional Biospecimen Repository collects biospecimens under Office for Human Research Protections (OHRP) and Health Insurance Portability and Accountability Act (HIPAA) guidelines and with local IRB approvals. Biospecimens are collected from consented HIV+ donors; NIH-funded HIV clinical treatment trials and anonymous remnant samples from HIV+ surgical and autopsy biospecimens (coded and anonymous samples from pathology archived, fixed and embedded materials); as well as other biorepositories as approved by biospecimen use and material transfer agreements.
Yes. The ACSR provides special biospecimen collections through tissue microarrays (TMA) and DNA libraries.
Yes. The ACSR does provide biospecimens to commercial entities, with the understanding that they are provided for research purposes only. Biospecimens and their products are not sold and may not be used for commercial purposes. Additionally biospecimens must NOT be distributed to third parties for purposes of sale or producing for sale.
Yes. The ACSR encourages scientific exploration and discovery in HIV/AIDS malignancies.
The ACSR solicits Letters of Intent (LOI) from investigators throughout the year with a minimum of paperwork. The application process is simple and straightforward. For more information, read How to Apply.
The Short Form LOI is designed for pilot studies where specimens are needed for test development, quality control, and/or preliminary research. The Short Form LOI allows a researcher to request up to 20 biospecimens on a one-time basis for a particular study. The Standard Form LOI is used for all other requests. For further clarification regarding the application process, please contact the ACSR via email at firstname.lastname@example.org
Electronic submission of completed Letters of Intent (LOIs) is preferred. For assistance, contact us.
Notification of approval or denial of biospecimens will be emailed 1-2 weeks from Short Form submissions and approximately 4-6 weeks from Standard LOI submissions.